Time-Lapse Imaging of Neuroblastoma Cells to Determine Cell Fate upon Gene Knockdown

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Batra, Richa ^a,b   Harder, Nathalie ^a,b   Gogolin, Sina ^b   Diessl, Nicolle ^b   Soons, Zita ^a,b   Jäger Schmidt, Christina ^b   Lawerenz, Christian ^b   Eils, Roland ^a,b   Rohr, Karl ^a,b   Westermann, Frank ^b   König, Rainer ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEFECTIVE IN SISTER CHROMATID COHESION 1 HOMOLOG PROTEIN; PROTEIN DLGAP5; REPLICATION FACTOR C; SINGLE STRANDED DNA BINDING PROTEIN; SINGLE STRANDED DNA BINDING PROTEIN 1; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMOOTHENED PROTEIN; TUMOR PROTEIN; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL FATE; CELL KINETICS; CELL PROLIFERATION; DLGAP5 GENE; DSCC1 GENE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SILENCING; GENETIC SCREENING; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR IMAGING; NEUROBLASTOMA; NEUROBLASTOMA CELL; PHENOTYPE; SMO GENE; SNRPD1 GENE; SSBP1 GENE; TIME LAPSE IMAGING; TUMOR GENE; UBE2C GENE; CELL TRANSFORMATION; GENETICS; METABOLISM; PROCEDURES; SPINDLE APPARATUS; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEUROBLASTOMA; SPINDLE APPARATUS; TIME-LAPSE IMAGING;

EID: 84871251601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050988     Document Type: Article

References (70)

1. Deyell RJ, Attiyeh EF, (2011) Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. Cancer Genet 204: 113-121.
2. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM, (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124.
3. Brodeur GM, (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
4. Westermann F, Muth D, Benner A, Bauer T, Henrich KO, et al. (2008) Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol 9: R150.
5. Obaya AJ, Mateyak MK, Sedivy JM, (1999) Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene 18: 2934-2941.
6. Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, et al. (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455: 930-935.
7. Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, et al. (2004) Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet 75: 727-730.
8. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
9. Li JJ, Li SA, (2006) Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Pharmacol Ther 111: 974-984.
10. Kavallaris M, (2010) Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 10: 194-204.
11. Gascoigne KE, Taylor SS, (2008) Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122.
12. Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, et al. (2006) Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 24: 5070-5078.
13. Willingham AT, Deveraux QL, Hampton GM, Aza-Blanc P, (2004) RNAi and HTS: exploring cancer by systematic loss-of-function. Oncogene 23: 8392-8400.
14. Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, et al. (2011) RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A 108: 3336-3341.
15. Holzel M, Huang S, Koster J, Ora I, Lakeman A, et al. (2010) NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell 142: 218-229.
16. Markowetz F, (2010) How to understand the cell by breaking it: network analysis of gene perturbation screens. PLoS Comput Biol 6: e1000655.
17. Harder N, Batra R, Gogolin S, Diessl N, Eils R, et al. (2011) Large-Scale Tracking for Cell Migration and Proliferation Analysis and Experimental Optimization of High-Throughput Screens. Proc 6th Internat Workshop on Microscopic Image Analysis with Applications in Biology (MIAAB '11).
18. Harder N, Mora-Bermudez F, Godinez WJ, Wunsche A, Eils R, et al. (2009) Automatic analysis of dividing cells in live cell movies to detect mitotic delays and correlate phenotypes in time. Genome Research 19: 2113-2124.
19. Bakal C, Aach J, Church G, Perrimon N, (2007) Quantitative morphological signatures define local signaling networks regulating cell morphology. Science 316: 1753-1756.
20. Conrad C, Erfle H, Warnat P, Daigle N, Lorch T, et al. (2004) Automatic identification of subcellular phenotypes on human cell arrays. Genome Res 14: 1130-1136.
21. Harder N, Mora-Bermudez F, Godinez WJ, Ellenberg J, Eils R, et al. (2006) Automated analysis of the mitotic phases of human cells in 3D fluorescence microscopy image sequences. Med Image Comput Comput Assist Interv 9: 840-848.
22. Fuchs F, Pau G, Kranz D, Sklyar O, Budjan C, et al. (2010) Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. Mol Syst Biol 6: 370.
23. Manchado E, Guillamot M, Malumbres M, (2012) Killing cells by targeting mitosis. Cell Death Differ 19: 369-377.
24. Vakifahmetoglu H, Olsson M, Zhivotovsky B, (2008) Death through a tragedy: mitotic catastrophe. Cell Death Differ 15: 1153-1162.
25. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, et al. (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 39: D691-697.
26. Neumann B, Held M, Liebel U, Erfle H, Rogers P, et al. (2006) High-throughput RNAi screening by time-lapse imaging of live human cells. Nat Methods 3: 385-390.
27. Bernard S, Cajavec Bernard B, Levi F, Herzel H, (2010) Tumor growth rate determines the timing of optimal chronomodulated treatment schedules. PLoS Comput Biol 6: e1000712.
28. Baguley BC, Marshall ES, (2004) In vitro modelling of human tumour behaviour in drug discovery programmes. Eur J Cancer 40: 794-801.
29. Zhang JD, Koerner C, Bechtel S, Bender C, Keklikoglou I, et al. (2011) Time-resolved human kinome RNAi screen identifies a network regulating mitotic-events as early regulators of cell proliferation. PLoS One 6: e22176.
30. Wong J, Lerrigo R, Jang CY, Fang G, (2008) Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain. Mol Biol Cell 19: 2083-2091.
31. Wong J, Fang G, (2006) HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture. J Cell Biol 173: 879-891.
32. Merkle CJ, Karnitz LM, Henry-Sanchez JT, Chen J, (2003) Cloning and characterization of hCTF18, hCTF8, and hDCC1. Human homologs of a Saccharomyces cerevisiae complex involved in sister chromatid cohesion establishment. J Biol Chem 278: 30051-30056.
33. Terret ME, Sherwood R, Rahman S, Qin J, Jallepalli PV, (2009) Cohesin acetylation speeds the replication fork. Nature 462: 231-234.
34. Pasca di Magliano M, Hebrok M, (2003) Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 3: 903-911.
35. Hirotsu M, Setoguchi T, Sasaki H, Matsunoshita Y, Gao H, et al. (2010) Smoothened as a new therapeutic target for human osteosarcoma. Mol Cancer 9: 5.
36. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, et al. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326: 572-574.
37. Yamanaka A, Hatakeyama S, Kominami K, Kitagawa M, Matsumoto M, et al. (2000) Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome. Mol Biol Cell 11: 2821-2831.
38. Nilsen TW, (2003) The spliceosome: the most complex macromolecular machine in the cell? Bioessays 25: 1147-1149.
39. Wong TS, Rajagopalan S, Townsley FM, Freund SM, Petrovich M, et al. (2009) Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53. Nucleic Acids Res 37: 568-581.
40. Richard DJ, Bolderson E, Cubeddu L, Wadsworth RI, Savage K, et al. (2008) Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 453: 677-681.
41. Jiang L, Bao Y, Luo C, Hu G, Huang C, et al. (2010) Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro. J Cancer Res Clin Oncol 136: 211-217.
42. Harrison MR, Holen KD, Liu G, (2009) Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins. Clin Adv Hematol Oncol 7: 54-64.
43. Lachmann A, Ma'ayan A, (2009) KEA: kinase enrichment analysis. Bioinformatics 25: 684-686.
44. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186.
45. Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr, et al. (2009) GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS One 4: e7443.
46. Wakefield JG, Stephens DJ, Tavare JM, (2003) A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 116: 637-646.
47. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, et al. (2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455: 1205-1209.
48. Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, et al. (2011) GSK-3beta inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. J Neurooncol 104: 145-153.
49. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, et al. (2008) Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res 68: 6643-6651.
50. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
51. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.
52. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
53. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4: 495-504.
54. Duan Z, Zhang J, Choy E, Harmon D, Liu X, et al. Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression is Critical for Osteosarcoma Cell Growth and Proliferation. Clin Cancer Res.
55. Benjamini Y, Hochberg Y, (1995) Controling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Statist Soc B 57: 289-300.
56. Kanda T, Sullivan KF, Wahl GM, (1998) Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol 8: 377-385.
57. Erfle H, Neumann B, Liebel U, Rogers P, Held M, et al. (2007) Reverse transfection on cell arrays for high content screening microscopy. Nat Protoc 2: 392-399.
58. Dimitriadou. E, Hornik.K, Leisch.F MD, Weingessel.A. (2011) Support Vector Machines-the Interface to libsvm in package e1071.
59. Wu C-JL T-F, Weng RC, (2004) Probability Estimates for Multi-class Classification by Pairwise Coupling. Journal of Machine Learning Research 5: 975-1005.
60. Brideau C, Gunter B, Pikounis B, Liaw A, (2003) Improved statistical methods for hit selection in high-throughput screening. J Biomol Screen 8: 634-647.
61. Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, et al. (2009) Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 6: 569-575.
62. Tuszynski.J (2012) caTools package.
63. Boutros M, Bras LP, Huber W, (2006) Analysis of cell-based RNAi screens. Genome Biol 7: R66.
64. Oberthuer A, Juraeva D, Li L, Kahlert Y, Westermann F, et al. (2010) Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients. Pharmacogenomics J 10: 258-266.
65. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
66. Hothorn T, Lausen B, (2003) On the exact distribution of maximally selected rank statistics. Computational Statistics and Data analysis.
67. Terry T (2012) A Package for Survival Analysis in S.
68. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
69. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA, (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
70. Alexa A, Rahnenfuhrer J, Lengauer T, (2006) Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600-1607.